Introduction:
The generic drug market in Canada has been experiencing steady growth in recent years, with an increased demand for affordable alternatives to brand-name medications. According to the Canadian Generic Pharmaceutical Association, generic drugs now account for over 70% of all prescriptions filled in Canada. This market report will highlight the top 10 generic drug market research and intelligence firms in Canada, providing valuable insights into the industry’s key players and their contributions to the market.
Top 10 Generic Drug Market Research & Intelligence Firms in Canada:
1. IQVIA Canada: With a market share of over 20%, IQVIA Canada is a leading provider of market research and intelligence for the generic drug industry in Canada. They offer comprehensive data and analytics to help companies make informed decisions.
2. Innomar Strategies: Innomar Strategies is known for its expertise in specialty pharmaceuticals, but they also provide valuable insights into the generic drug market in Canada. They have a strong presence in the market, with a focus on market access and distribution strategies.
3. Kantar Health Canada: Kantar Health Canada is a trusted name in healthcare market research, offering insights into the generic drug market and trends shaping the industry. Their data-driven approach helps clients navigate the complex landscape of the Canadian pharmaceutical market.
4. Leger: Leger is a leading market research firm in Canada, providing valuable intelligence on consumer behavior and preferences in the generic drug market. With a focus on customer satisfaction and brand perception, Leger helps companies optimize their marketing strategies.
5. IMS Brogan: IMS Brogan is a key player in the Canadian pharmaceutical market, offering insights into the generic drug industry and competitive landscape. Their data-driven approach helps companies identify growth opportunities and make strategic decisions.
6. McKesson Canada: McKesson Canada is a major player in the distribution of generic drugs, with a strong presence in the Canadian market. They provide valuable intelligence on market trends and supply chain management, helping companies optimize their operations.
7. QuintilesIMS: QuintilesIMS is a global leader in healthcare market research, with a strong presence in the Canadian generic drug market. They offer comprehensive data and analytics to help companies track market trends and make informed decisions.
8. Janssen Canada: Janssen Canada is a leading pharmaceutical company with a focus on generic drugs and biosimilars. They provide valuable insights into market dynamics and regulatory trends, helping companies navigate the evolving landscape of the Canadian pharmaceutical industry.
9. Teva Canada: Teva Canada is a major player in the Canadian generic drug market, with a wide range of products and a strong distribution network. They offer valuable intelligence on market trends and pricing strategies, helping companies stay competitive in the market.
10. Sandoz Canada: Sandoz Canada is a key player in the Canadian generic drug market, with a focus on quality and affordability. They provide valuable insights into market dynamics and regulatory issues, helping companies navigate the complex landscape of the industry.
Insights:
Looking ahead, the Canadian generic drug market is expected to continue its growth trajectory, driven by increasing demand for affordable medications and ongoing patent expirations. According to a recent report by Market Research Future, the Canadian generic drug market is projected to reach a value of over $10 billion by 2025, with a CAGR of around 8%. This growth presents significant opportunities for market research and intelligence firms to provide valuable insights and support to companies looking to capitalize on this expanding market. As competition intensifies and regulations evolve, staying informed and leveraging data-driven strategies will be key for success in the Canadian generic drug market.
Related Analysis: View Previous Industry Report
